All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
CAMBRIA-2: Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next-Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine T
CAMBRIA-2: Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next-Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients with ER /HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
CAPItello-281
The purpose of this study is to compare the effects, good or bad of an investigational product, capivasertib added to standard treatments in patients who are newly diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC) and your cancer has low levels of a protein called PTEN (or “PTEN deficiency”).
Celgene - Do you have Eosinophilic Esophagitis and difficulty swallowing?
A multicentre study of the safety and effectiveness of CC-93538 in adolescent and adult participants with Eosinophilic Esophagitis
CIC-E-301: a potential new combination vaccine for COVID-19 and flu
The Sponsor is developing a combination vaccine that aims to prevent serious illness or infection of both the flu virus and SARS-CoV-2 virus in people who are at least 65 or more years old.
CROSSING - A new treatment for Eosinophilic Esophagitis
A study of the safety and effectiveness of tezepelumab in adolescent and adult participants with Eosinophilic Esophagitis
DEPART - Seeking cancer patients with nerve pain
Duloxetine versus pregabalin to treat opioid-resistant nerve pain in cancer patients.
DYNASTY-Breast02
The purpose of this trial is to assess the effectiveness of DB-1303 in the treatment of hormone receptor positive, HER2-low breast cancer, compared to standard of care.
ELAINE-3
An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men with Locally Advanced or Metastatic ER+/HER2− Breast Cancer with an ESR1 Mutation.
ElevAAte - New Treatment for Adults with Alpha-1 Antitrypsin Deficiency (AATD) Emphysems
Study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD Emphysema
EMERALD2 - A new treatment for Ulcerative Colitis
A phase 2b study to evaluate MORF-057 in adults with moderately to severely active ulcerative colitis (UC).